CareDx, Inc. (CDNA) stock forecast and price target
Price $77.88 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($77.88)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $1.78 | +206.7% | $525M |
| Next fiscal year ends December 31, 2027 | $1.56 | −12.0% | $572M |
| Next quarter ends December 31, 2026 | $0.36 | +200.0% | $136M |
| Quarter after ends March 31, 2027 | $0.31 | −9.2% | $131M |
Consensus of the analysts covering CareDx, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 21.2% upside over 12 months. Our discounted cash flow model with moderate assumptions puts CareDx’s intrinsic value about 78% below today’s market value, and it scores 1.6 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the CareDx stock price target?
The average 12-month target from 7 analysts is $94.43, 21.2% above the current price of $77.88 Targets range from $90.00 to $100.00.
Is CareDx a buy according to analysts?
The consensus rating is “Buy” (1 strong buy, 5 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is CareDx expected to earn?
Analysts expect EPS of $1.78 for the fiscal year ending December 31, 2026 and $1.56 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.